Kirstein, Martha M.

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 1,294

Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma

Schulte, L., Scheiner, B., Voigtländer, T., Koch, S., Schweitzer, N., Marhenke, S., Ivanyi, P., Manns, M. P., Rodt, T., Hinrichs, J. B., et al. (2019) · Liver International

Metabolism, Diabetes, and CancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 67

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis

Taubert, R., Diestelhorst, J., Junge, N., Kirstein, M. M., Pischke, S., Vogel, A., Bantel, H., Baumann, U., Manns, M. P., Wedemeyer, H., et al. (2018) · Scientific Reports

Liver Diseases and ImmunityHepatitis B Virus Studies

Cited by 29